DEPOMED INC - NOTE 2.500% 9/0

Historical Holders from Q2 2014 to Q3 2021

Type / Class
Debt / NOTE 2.500% 9/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of DEPOMED INC - NOTE 2.500% 9/0 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2021 Q3 $0 $0 -$3,000 0
2021 Q2 $4,000 $3,000 75.0% 1
2021 Q1 $4,000 $3,000 -$2,000 75.0% 1
2020 Q4 $6,000 $5,000 87.5% 2
2020 Q3 $6,000 $5,000 -$5,000 87.5% 2
2020 Q2 $11,000 $11,000 -$13,188,921 100.0% 3
2020 Q1 $13,311,500 $13,199,921 -$79,861,562 99.0% 11
2019 Q4 $123,156,000 $90,482,819 +$477,525 73.96% 22
2019 Q3 $122,352,000 $90,590,817 -$144,652,339 74.47% 24
2019 Q2 $318,389,000 $230,024,755 +$34,453,726 72.4% 30
2019 Q1 $270,154,000 $208,283,000 -$22,370,340 77.0% 28
2018 Q4 $310,691,000 $211,591,000 +$210,411,570 67.69% 30
2018 Q3 $1,755,000 $1,385,000 -$252,336,977 78.92% 1
2018 Q2 $308,879,000 $253,763,000 +$19,234,880 81.69% 37
2018 Q1 $285,523,000 $233,895,000 -$3,988,097 81.46% 35
2017 Q4 $290,887,000 $245,713,000 +$33,161,557 84.4% 39
2017 Q3 $255,764,000 $189,634,000 -$24,894,132 74.17% 46
2017 Q2 $283,099,000 $249,751,890 -$48,948,399 88.09% 43
2017 Q1 $335,189,000 $314,681,974 -$12,314,051 93.85% 49
2016 Q4 $343,144,000 $391,852,666 +$1,782,374 113.88% 49
2016 Q3 $335,292,000 $478,575,490 -$14,809,301 142.66% 48
2016 Q2 $336,321,002 $405,408,308 +$19,370,310 120.67% 42
2016 Q1 $335,461,000 $314,848,891 +$1,957,780 93.44% 42
2015 Q4 $325,223,000 $370,676,000 -$2,453,030 114.0% 37
2015 Q3 $332,797,000 $396,598,000 -$4,119,294 119.18% 42
2015 Q2 $340,297,000 $436,443,000 +$18,864,848 128.15% 42
2015 Q1 $313,151,000 $414,217,716 +$27,191,681 132.19% 44
2014 Q4 $278,758,000 $302,190,000 -$4,997,289 108.12% 36
2014 Q3 $291,445,000 $308,479,000 +$271,430,930 105.59% 36
2014 Q2 $14,500,000 $15,167,000 +$15,167,000 104.6% 1